Active Surveillance in Intermediate-Risk Patients: Overall and Cause-Specific Survival From a Large Single-Institution Experience

被引：0
|
作者：
Musunuru, H. B. [1 ]
Klotz, L. [2 ]
Vesprini, D. [3 ]
Zhang, L. [1 ]
Mamedov, A. [3 ]
Sethukavalan, P. [3 ]
Jethava, V. [2 ]
Jain, S. [4 ]
Yamamoto, T. [2 ]
Loblaw, D. A. [3 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook Hlth Sci, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[4] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1112
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2558
引用
收藏
页码：E224 / E224
页数：1
相关论文
共 50 条
  • [41] Prognostic nomograms for predicting overall survival and cause-specific survival of signet ring cell carcinoma in colorectal cancer patients
    Kou, Fu-Rong
    Zhang, Yang-Zi
    Xu, Wei-Ran
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (11) : 2503 - 2518
  • [42] Focal therapy using HIFU for intermediate-risk localized prostate cancer: initial experience of single institution in Malaysia
    Khor, Vincent
    Chiu, Peter Ka-Fung
    Fahmy, Omar
    Khairul-Asri, Mohd Ghani
    BJU INTERNATIONAL, 2024, 134 : 17 - 18
  • [43] Improved Risk Stratification of MDS Patients With IPSS-M: A Single-Institution Experience
    Kurt, Habibe
    Chergui, Adel
    Omer, Mohamed
    Reagan, John L.
    Olszewski, Adam J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S402 - S402
  • [44] Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience
    Rok Petric
    Barbara Gazic
    Nikola Besic
    BMC Cancer, 14
  • [45] Patterns of surveillance for colorectal cancer: Experience from a single large tertiary institution
    Pellegrino, Samantha A.
    Chan, Steven
    Simons, Koen
    Kinsella, Rita
    Gibbs, Peter
    Faragher, Ian G.
    Deftereos, Irene
    Mc Yeung, Justin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (04) : 343 - 349
  • [46] Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis
    Mason Webb
    Derek R. Johnson
    Anita Mahajan
    Paul Brown
    Bryan Neth
    Sani H. Kizilbash
    Ugur Sener
    Journal of Neuro-Oncology, 2022, 160 : 527 - 534
  • [47] Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis
    Webb, Mason
    Johnson, Derek R.
    Mahajan, Anita
    Brown, Paul
    Neth, Bryan
    Kizilbash, Sani H.
    Sener, Ugur
    JOURNAL OF NEURO-ONCOLOGY, 2022, 160 (02) : 527 - 534
  • [48] Testosterone recovery as biomarker for overall and cause-specific survival in combined treated patients with high-risk and locally advanced prostate cancer
    Deek, Mathew
    Vaage, Victoria
    Hole, Knut H.
    DeWeese, Theodore L.
    Stensvold, Andreas
    Seierstad, Therese
    Tran, Phuoc T.
    Lilleby, Wolfgang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [49] Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer A Single-Institution 21-Year Experience
    Wu, Shannon S.
    Lamarre, Eric D.
    Yalamanchali, Anirudh
    Brauer, Philip R.
    Hong, Hanna
    Reddy, Chandana A.
    Yilmaz, Emrullah
    Woody, Neil
    Ku, Jamie A.
    Prendes, Brandon
    Burkey, Brian
    Nasr, Christian
    Skugor, Mario
    Heiden, Katherine
    Chute, Deborah J.
    Knauf, Jeffrey A.
    Campbell, Shauna R.
    Koyfman, Shlomo A.
    Geiger, Jessica L.
    Scharpf, Joseph
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2023, 149 (04) : 300 - 309
  • [50] Prognostic nomograms for predicting cause-specific survival and overall survival of stage I-III colon cancer patients: a large population-based study
    Zhou, Zheng
    Mo, Shaobo
    Dai, Weixing
    Xiang, Wenqiang
    Han, Lingyu
    Li, Qingguo
    Wang, Renjie
    Liu, Lu
    Zhang, Long
    Cai, Sanjun
    Cai, Guoxiang
    CANCER CELL INTERNATIONAL, 2019, 19 (01)
12345